Kenneth W. O'Keefe, Director at Jazz Pharmaceuticals plc (JAZZ), sold 5,380 shares at $138.39 ($745K) on 2023-03-07, disclosed to the SEC on 2023-03-09.
Open-market sale of $745k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.39 | 2,690 | $372K | 50.0% |
| 2 | $138.39 | 2,690 | $372K | 50.0% |
| Total | $138.39 avg | 5,380 | $745K | 100% |
| Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-11-09 | $3.4M | — | Filing → |
| JAZZ | SELL | 2020-08-10 | $234K | — | Filing → |